Acerus Pharmaceuticals Corporation ASPCF
0.22 0.00 (+0.00%)
Jan 12, 2023, 9:53 AM EST
0.21988 Day range 0.21988
0.21988 52-week range 8.16
News
defenseworld.net China Pharma (NYSE:CPHI) & Acerus Pharmaceuticals (OTCMKTS:ASPCF) Financial Comparison Volatility and Risk Acerus Pharmaceuticals has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Comparatively, China Pharma has a beta of 1.08, meaning that its…
defenseworld.net Critical Review: Acerus Pharmaceuticals (OTCMKTS:ASPCF) vs. Zymeworks (NASDAQ:ZYME) Acerus Pharmaceuticals (OTCMKTS:ASPCF - Get Free Report) and Zymeworks (NASDAQ: ZYME - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the…
globenewswire.com Acerus Update TORONTO, July 10, 2023 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company”) announces that, in connection with its creditor protection proceedings under the Companies' Creditors…
seekingalpha.com Acerus Pharmaceuticals Corporation (ASPCF) CEO Edward Gudaitis on Q2 2022 Results - Earnings Call Transcript Acerus Pharmaceuticals Corporation (OTCQB:ASPCF) Q2 2022 Earnings Conference Call August 9, 2022 10:00 AM ET Company Participants Edward Gudaitis - President & Chief Executive Officer Robert Motz -…
globenewswire.com Acerus to Report Q2-2022 Financial Results and Host Investor Call TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its second quarter 2022 financial and operating results on Tuesday, August 9, 2022…
globenewswire.com Acerus To Report Q4 And Full Year 2021 Financial Results And Host Investor Call TORONTO, March 10, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its fourth quarter and full year 2021 financial and operating results on Tuesday,…
seekingalpha.com Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q3 2021 Results - Earnings Call Transcript Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q3 2021 Results - Earnings Call Transcript
globenewswire.com Acerus to Report Q3-2021 Financial Results and Host Investor Call TORONTO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its third quarter 2021 financial and operating results on Tuesday, November 9, 2021…
globenewswire.com Acerus Announces Participation in HC Wainwright Conference TORONTO, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP; OTCQB:ASPCF) today announced that it will participate in the H.C. Wainwright 23rd…
globenewswire.com Acerus Reports Acceptance of Part 36 Settlement Offer in Recipharm Litigation TORONTO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP; OTCQB:ASPCF) today announced that it had accepted a Part 36 settlement offer made…
seekingalpha.com Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q2 2021 Results - Earnings Call Transcript Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q2 2021 Results - Earnings Call Transcript
globenewswire.com Acerus Reports Fiscal 2021 Second Quarter Financial Results Revenue Triples after Buyback of US Rights for NATESTO® Revenue Triples after Buyback of US Rights for NATESTO®
globenewswire.com Acerus to Report Q2-2021 Financial Results and Host Investor Call TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its second quarter 2021 financial and operating results on Tuesday, August 10, 2021…
globenewswire.com Acerus Provides Update on Litigation with Recipharm TORONTO, July 12, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP, OTCQB:ASPCF) today announced that, on June 15, 2021, it prevailed at a preliminary…
globenewswire.com Acerus Announces New PBM Contract, Significantly Expanding NATESTO® Insurance Coverage in the United States NATESTO® Coverage now Includes 85% of Commercial Lives NATESTO® Coverage now Includes 85% of Commercial Lives
benzinga.com Stocks That Hit 52-Week Lows On Tuesday 
benzinga.com Stocks That Hit 52-Week Lows On Thursday - benzinga.com Stocks That Hit 52-Week Lows On Tuesday
benzinga.com Stocks That Hit 52-Week Lows On Monday